Endologix Inc
ELGX
ELGX was delisted on the 15th of July, 2020.
97 hedge funds and large institutions have $354M invested in Endologix Inc in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 14 closing their positions.
107% more call options, than puts
Call options by funds: $89K | Put options by funds: $43K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 103 → 97 (-6)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
27% less capital invested
Capital invested by funds: $482M → $354M (-$128M)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$5.58M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.51M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.32M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$424K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.91M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$3.78M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$3.51M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$2.36M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.94M |
ELGX Hedge Fund Activity: Q1 2018 in Review
97 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q1 2018, worth a combined $354M — down 27% from $482M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ELGX and 9 opened new positions — a net loss of 5 holders — while 34 trimmed existing stakes and 30 added.
The largest buyer was Camber Capital Management, adding an estimated $5.58M. The largest seller was Vanguard Group, cutting an estimated $6.91M.
- 97 institutional investors held Endologix Inc (ELGX) as of Q1 2018, down from 103 in Q4 2017.
- Funds reported $354M of Endologix Inc stock for Q1 2018, down 27% quarter-over-quarter.
- 9 funds opened new Endologix Inc positions in Q1 2018 and 14 closed out, a net change of -5 holders.
- The largest Endologix Inc buyer in Q1 2018 was Camber Capital Management, an estimated $5.58M added.
- The largest Endologix Inc seller in Q1 2018 was Vanguard Group, an estimated $6.91M sold.
Based on aggregated 13F filings for Q1 2018.